PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 18031543-5 2008 Furthermore, we also found that sHA treatment enhanced the motility of melanoma cells, an effect that could again be blocked by TLR4-specific siRNA. salicylhydroxamic acid 32-35 toll like receptor 4 Homo sapiens 128-132 18031543-6 2008 Together, our results suggest that sHA in melanoma might promote tumor invasiveness by inducing MMP- and cytokine-expression, in part in a TLR4-dependent manner, providing new insights into the relationship between cancer and innate immunity. salicylhydroxamic acid 35-38 toll like receptor 4 Homo sapiens 139-143